Baxter BioPharma Solutions Spring Show Guide

Article

BioPharma Solutions, a business unit of Baxter, partners with pharmaceutical companies to support their commercialization objectives by providing scientific expertise, sterile contract manufacturing solutions, parenteral delivery systems, and customized support services needed to meet the unique challenges that parenteral products face. As a parenterals specialist with over 80 years of expertise, BioPharma Solutions offers unique drug delivery systems and a variety of contract manufacturing form/fill/finish services and solutions for injectables designed to meet complex and traditional sterile manufacturing challenges.

E-mail: biopharmasolutions@baxer.com

Website: www.baxterbiopharmasolutions.com

Shows attending:

  • BIO - booth 2855

  • Interphex - booth 3913

  • ICSE (Frankfurt) - booth 42-G21
Recent Videos
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Mike Baird from Schlafender Haser discusses industry trends from 2024 and those expected to have an impact in 2025 from the perspective of a software developer.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes
Related Content
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

FDA Makes Class-Wide Labeling Changes to Testosterone Products

Patrick Lavery
March 6th 2025
Article

The alterations are the result of an agency review of findings from a clinical trial, and data from required postmarket studies.

Drug Solutions Podcast: Forecasting Pharma’s Future

Drug Solutions Podcast: Forecasting Pharma’s Future

Felicity Thomas
January 31st 2025
Podcast

This episode is a compilation of comments taken from a series of interviews where experts reveal the trends that have impacted the bio/pharma industry in 2024 and those they expect to be impactful in 2025.

Business cooperation strategy to create value for customers achieve the goal. | Image Credit: © Thanadon88 - stock.adobe.com

Adopting Flexible Strategies to Combat Capacity Shortages

Patrick Lavery
March 6th 2025
Article

More and more contract manufacturers have been looking not at what the state of the supply chain is right now, but what it may be in the next three to five years.

Drug Solutions Podcast: Realizing AI’s Potential

Drug Solutions Podcast: Realizing AI’s Potential

Felicity Thomas
December 20th 2024
Podcast

This episode is a compilation of comments taken from a series of interviews where experts are discussing how AI might impact the global bio/pharma industry in the future.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

CordenPharma Selects Switzerland Site for Peptide Manufacturing Facility

Patrick Lavery
March 5th 2025
Article

The company first announced its intention to build the state-of-the-art facility as part of a €900 million investment in July 2024.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

Nelson Labs Launches Rapid Sterility Testing, Cutting Incubation Times

Patrick Lavery
March 4th 2025
Article

The company now performs product-sterility testing through rapid microbiological methods at two laboratory sites in the United States and one in Germany.